Related Experiment Videos
Biochemical, hematologic, and immunologic alterations following hepatic cryotherapy
1Department of Surgery, Virginia Commonwealth University 23298, USA.
Seminars in Surgical Oncology
|March 11, 1998
Summary
Hepatic cryosurgery uses freezing to damage liver cancer cells, causing temporary changes in blood markers and potentially boosting anti-tumor immunity. Long-term side effects are rare and manageable.
Area of Science:
- Hepatobiliary Surgery
- Cryobiology
- Surgical Oncology
Background:
- Hepatic cryosurgery is a technique used to treat liver tumors.
- The procedure involves inducing cell death through freezing.
- Understanding the effects of cryosurgery on liver tissue and systemic parameters is crucial.
Purpose of the Study:
- To detail the mechanisms of hepatocellular damage induced by cryosurgery.
- To examine the biochemical and hematologic alterations following hepatic cryosurgery.
- To investigate the potential immunomodulatory effects of cryosurgery.
Main Methods:
- Cryosurgery involves inducing hepatocellular damage via ice crystal formation.
- Multiple freeze-thaw cycles can enhance cell necrosis.
- Alterations in liver function tests, bilirubin, myoglobin, platelets, and coagulation were assessed.
Main Results:
- Cryosurgery causes hepatocellular damage and necrosis, particularly with multiple freeze-thaw cycles.
- Biochemical and hematologic parameters (e.g., liver function tests, myoglobin, platelets) show transient changes.
- Experimental models suggest cryosurgery may stimulate an anti-tumor immune response.
Conclusions:
- Hepatic cryosurgery effectively damages liver cells through freezing.
- Associated biochemical and hematologic changes are typically transient.
- Cryosurgery shows potential for inducing an anti-tumor immune response with minimal long-term sequelae.